Oncofetal protein IMP3: A new diagnostic biomarker for laryngeal carcinoma

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2126-2131

  Chen, Kai ^a   Cornejo, Kristine M ^b   Ye, Weijun ^a   Wu, Qiuliang ^a   Liang, Jianzhong ^a   Jiang, Zhong ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Diagnostic biomarker; IMP3; Laryngeal carcinoma; Squamous cell carcinoma

Indexed keywords

IMP3 PROTIEN; ONCOFETAL ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RETRIEVAL; ARTICLE; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; INVASIVE CARCINOMA; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM;

DIAGNOSTIC BIOMARKER; IMP3; LARYNGEAL CARCINOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; NEOPLASM INVASIVENESS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884418118     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.04.002     Document Type: Article

References (33)

1. E.A. Chu, and Y.J. Kim Laryngeal cancer: diagnosis and preoperative work-up Otolaryngol Clin North Am 41 2008 673 695
2. L. Licitra, J. Bernier, and C. Grandi Cancer of the larynx Crit Rev Oncol Hematol 47 2003 65 80
3. L. Mao, W.K. Hong, and V.A. Papadimitrakopoulou Focus on head and neck cancer Cancer Cell 5 2004 311 316
4. G. Marioni, R. Marchese-Ragona, G. Cartei, F. Marchese, and A. Staffieri Current opinion in diagnosis and treatment of laryngeal carcinoma Cancer Treat Rev 32 2006 504 515
5. Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2009-pops09/, based on November 2011 SEER data submission, posted to the SEER Web site, 2012; p 8.
6. E.E. Remijn, H.A. Marres, and F.J. van den Hoogen Endoscopic laser treatment in pre-malignant and malignant vocal fold epithelial lesions J Laryngol Otol 116 2002 1019 1024
7. M. Sadri, J. McMahon, and A. Parker Management of laryngeal dysplasia: a review Eur Arch Otorhinolaryngol 263 2006 843 852
8. D.L. Figueiredo, R.C. Mamede, and G.C. Spagnoli High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx Head Neck 33 2011 702 707
9. L. Tamas, G. Szentkuti, and M. Eros Differential biomarker expression in head and neck cancer correlates with anatomical localization Pathol Oncol Res 17 2011 721 727
10. K. Deniz, I. Yuce, S. Cagli, T. Okten, and E. Guney Expression of PCNA and bcl-2 in basaloid squamous cell carcinoma of the larynx: a controlled study Ear Nose Throat J 87 2008 469 473
11. R. Cabanillas, J.P. Rodrigo, P. Secades, A. Astudillo, C.S. Nieto, and M.D. Chiara The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer J Surg Oncol 99 2009 373 378
12. Y. Liu, X.L. Dong, C. Tian, and H.G. Liu Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx Diagn Pathol 7 2012 34
13. Y. Liu, L.P. Gong, X.L. Dong, and H.G. Liu Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization Diagn Cytopathol 41 2013 515 519
14. F. Mueller-Pillasch, B. Pohl, and M. Wilda Expression of the highly conserved RNA binding protein KOC in embryogenesis Mech Dev 88 1999 95 99
15. F.C. Nielsen, J. Nielsen, and J. Christiansen A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking Scand J Clin Lab Invest Suppl 234 2001 93 99
16. Z. Jiang, P.G. Chu, and B.A. Woda Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study Lancet Oncol 7 2006 556 564
17. R.K. Yantiss, B.A. Woda, and G.R. Fanger KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas Am J Surg Pathol 29 2005 188 195
18. Z. Jiang, P.G. Chu, and B.A. Woda Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas Clin Cancer Res 14 2008 5579 5584
19. Z. Jiang, C.M. Lohse, and P.G. Chu Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas Cancer 112 2008 2676 2682
20. N.E. Hoffmann, Y. Sheinin, and C.M. Lohse External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma Cancer 112 2008 1471 1479
21. D. Lu, P. Vohra, P.G. Chu, B. Woda, K.L. Rock, and Z. Jiang An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia Am J Surg Pathol 33 2009 521 525
22. W. Zheng, X. Yi, and O. Fadare The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma Am J Surg Pathol 32 2008 304 315
23. T. Wang, L. Fan, and Y. Watanabe L523S, an RNA-binding protein as a potential therapeutic target for lung cancer Br J Cancer 88 2003 887 894
24. L. Sitnikova, G. Mendese, and Q. Liu IMP3 predicts aggressive superficial urothelial carcinoma of the bladder Clin Cancer Res 14 2008 1701 1706
25. M. Shi, A.E. Fraire, and P. Chu Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation Am J Surg Pathol 35 2011 878 882
26. K. Cornejo, M. Shi, and Z. Jiang Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma Hum Pathol 43 2012 1567 1572
27. B. Liao, Y. Hu, D.J. Herrick, and G. Brewer The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells J Biol Chem 280 2005 18517 18524
28. J. Vikesaa, T.V. Hansen, and L. Jonson RNA-binding IMPs promote cell adhesion and invadopodia formation EMBO J 25 2006 1456 1468
29. L. Barnes, L.L.Y. Tse, and J.L. Hunt Tumours of the hypopharynx, larynx and trachea L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky, Pathology & genetics of head and neck tumours (IARC WHO classification of tumours) 2005 IARC Press Lyon, France 108 162
30. C. Li, V. Zota, and B.A. Woda Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations Mod Pathol 20 2007 1263 1268
31. C. Li, K.L. Rock, B.A. Woda, Z. Jiang, A.E. Fraire, and K. Dresser IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression Mod Pathol 20 2007 242 247
32. D. Lu, X. Yang, and N.Y. Jiang IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer Am J Surg Pathol 35 2011 1638 1645
33. S. Li, J. Cha, and J. Kim Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma Head Neck 33 2011 368 374